Tevogen Bio Holdings (TVGN) Other Non-Current Assets (2021 - 2026)

Tevogen Bio Holdings (TVGN) reported Other Non-Current Assets of $1.1 million for Q1 2026, up 85.1% on a YoY basis from $575841.0 in Q1 2025, and little changed quarter-over-quarter from $1.1 million in Q4 2025.

Tevogen Bio Holdings (TVGN) Other Non-Current Assets (2021 - 2026) Analysis & Trends

Tevogen Bio Holdings has reported Other Non-Current Assets for 6 years, with the latest figure at $1.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets rose 85.1% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 85.1% YoY), and the FY2025 full-year result was $1.1 million, up 85.1% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $1.1 million, roughly flat from $1.1 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $2.6 million in Q4 2023, with the low at $38947.0 in Q1 2022.
  • Historically, Other Non-Current Assets has averaged $641991.4 across 5 years, with a median of $565884.0 in 2025.
  • Annual changes were most pronounced in 2024 — Other Non-Current Assets plunged 77.71% — and 2025, when it jumped 332.07%.
  • Tevogen Bio Holdings' Other Non-Current Assets stood at $38947.0 in 2022, then surged by 6531.76% to $2.6 million in 2023, then sank by 77.71% to $575841.0 in 2024, then jumped by 85.1% to $1.1 million in 2025, then grew by 0.0% to $1.1 million in 2026.
  • The last three Other Non-Current Assets figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $190923.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 289.41 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 60,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 1.26 Bn
9 Abivax 94.26 Bn 94.26 Bn - -
10 Tevogen Bio Holdings 182.04 Mn 181.35 Mn - 1.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.07 Mn
Dec 31, 2025 1.07 Mn
Sep 30, 2025 190,923.00
Jun 30, 2025 565,884.00
Mar 31, 2025 575,841.00
Dec 31, 2024 575,841.00
Sep 30, 2024 133,276.00
Jun 30, 2024 133,276.00
Mar 31, 2024 133,276.00
Dec 31, 2023 2.58 Mn
Mar 31, 2022 38,947.00
Dec 31, 2021 145,170.00